Carbamate compounds for use in treating neurodegenerative disorders

Details for Australian Patent Application No. 2005295787 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Zhao, Boyu; Twyman, Roy E.

Agent Shelston IP

Pub. Number AU-A-2005295787

PCT Pub. Number WO2006/044472

Priority 60/619,402 15.10.04 US; 60/698,403 12.07.05 US

Filing date 14 October 2005

Wipo publication date 27 April 2006

International Classifications

A61K 31/27 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/044472 Priority application(s): WO2006/044472

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295788-N-benzenesulfonyl substituted anilinopyrimidine analogs

2005295786-System and method for facilitating a wireless financial transaction